213 related articles for article (PubMed ID: 28110868)
21. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
23. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
Thomas KD; Adhikari AV; Chowdhury IH; Sandeep T; Mahmood R; Bhattacharya B; Sumesh E
Eur J Med Chem; 2011 Oct; 46(10):4834-45. PubMed ID: 21880400
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides.
Marvadi SK; Krishna VS; Surineni G; Srilakshmi Reshma R; Sridhar B; Sriram D; Kantevari S
Bioorg Chem; 2020 Mar; 96():103626. PubMed ID: 32007719
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
[TBL] [Abstract][Full Text] [Related]
28. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
[TBL] [Abstract][Full Text] [Related]
29. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
[TBL] [Abstract][Full Text] [Related]
30. Ring-substituted quinolines as potential anti-tuberculosis agents.
Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones.
de Macedo MB; Kimmel R; Urankar D; Gazvoda M; Peixoto A; Cools F; Torfs E; Verschaeve L; Lima ES; Lyčka A; Milićević D; Klásek A; Cos P; Kafka S; Košmrlj J; Cappoen D
Eur J Med Chem; 2017 Sep; 138():491-500. PubMed ID: 28689097
[TBL] [Abstract][Full Text] [Related]
32. New bithiazolyl hydrazones: Novel synthesis, characterization and antitubercular evaluation.
Bhalerao MB; Dhumal ST; Deshmukh AR; Nawale LU; Khedkar V; Sarkar D; Mane RA
Bioorg Med Chem Lett; 2017 Jan; 27(2):288-294. PubMed ID: 27914801
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
35. Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents.
Singh R; Nawale L; Arkile M; Wadhwani S; Shedbalkar U; Chopade S; Sarkar D; Chopade BA
Int J Nanomedicine; 2016; 11():1889-97. PubMed ID: 27217751
[TBL] [Abstract][Full Text] [Related]
36. Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.
Dongamanti A; Aamate VK; Devulapally MG; Gundu S; Balabadra S; Manga V; Yogeeswari P; Sriram D; Balasubramanian S
Mol Divers; 2017 Nov; 21(4):999-1010. PubMed ID: 28840414
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis.
Chitre TS; Asgaonkar KD; Miniyar PB; Dharme AB; Arkile MA; Yeware A; Sarkar D; Khedkar VM; Jha PC
Bioorg Med Chem Lett; 2016 May; 26(9):2224-8. PubMed ID: 27017114
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents.
Gholap S; Tambe M; Nawale L; Sarkar D; Sangshetti J; Damale M
Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29292534
[TBL] [Abstract][Full Text] [Related]
39. Quinoline Based Monocarbonyl Curcumin Analogs as Potential Antifungal and Antioxidant Agents: Synthesis, Bioevaluation and Molecular Docking Study.
Nagargoje AA; Akolkar SV; Siddiqui MM; Subhedar DD; Sangshetti JN; Khedkar VM; Shingate BB
Chem Biodivers; 2020 Feb; 17(2):e1900624. PubMed ID: 31863703
[TBL] [Abstract][Full Text] [Related]
40. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]